A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies)
Clinical trial NCT03671148 · COMPLETED
Trial details
- NCT number
- NCT03671148
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2020-06-22
- Enrollment
- 444
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.